Your browser doesn't support javascript.
loading
Extending Treatment Intervals of R-CHOP Therapy Might Be Acceptable for Some Patients with Non-indolent Non-Hodgkin's B-cell Lymphoma.
Fujishita, Keigo; Yasuhisa, Sando; Oka, Satoshi; Fujisawa, Yuka; Machida, Takuya; Imai, Toshi.
  • Fujishita K; Department of Hematology and Blood Transfusion, Kochi Health Sciences Center.
  • Yasuhisa S; Department of Hematology and Blood Transfusion, Kochi Health Sciences Center.
  • Oka S; Department of Hematology and Blood Transfusion, Kochi Health Sciences Center.
  • Fujisawa Y; Department of Hematology and Blood Transfusion, Kochi Health Sciences Center.
  • Machida T; Department of Hematology and Blood Transfusion, Kochi Health Sciences Center.
  • Imai T; Department of Hematology and Blood Transfusion, Kochi Health Sciences Center.
Acta Med Okayama ; 76(1): 17-24, 2022 Feb.
Article en En | MEDLINE | ID: mdl-35236994
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B / Antineoplásicos Hormonales / Antineoplásicos Inmunológicos / Antibióticos Antineoplásicos / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B / Antineoplásicos Hormonales / Antineoplásicos Inmunológicos / Antibióticos Antineoplásicos / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2022 Tipo del documento: Article